Cutaneous Effects of the Most Commonly Used Antidepressant Medication, the Selective Serotonin Reuptake Inhibitors

    December 2006 in “ Journal of The American Academy of Dermatology ”
    Dorota Krasowska, Magdalena Szymanek, Robert A. Schwartz, Wojciech Myśliński
    Image of study
    TLDR Antidepressants called SSRIs can cause skin problems, bleeding risk, and other side effects.
    In the 2007 study by Krasowska et al., selective serotonin reuptake inhibitors (SSRIs) were associated with various skin reactions, including serious conditions like Stevens-Johnson syndrome and toxic epidermal necrolysis, as well as alopecia and other skin issues. SSRIs were also linked to hematologic complications like increased bleeding risk due to their impact on platelet function, which are typically reversible after stopping the medication. Additionally, SSRIs may cause noncutaneous side effects such as galactorrhea, extrapyramidal symptoms, and an increased risk for conditions like osteoporosis and breast cancer. The study suggests that the incidence of these side effects is proportional to the number of patients taking SSRIs and underscores the need for awareness of potential adverse reactions when prescribing these drugs. The number of participants in the study was not mentioned.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 1000+ results

      community EU Shouldn't Ban Fin & Dut: PFS is NOT REAL.

      in Research/Science  11 upvotes 9 months ago
      Finasteride and Dutasteride do not cause depression or "Post Finasteride Syndrome," with concerns often linked to the nocebo effect and preexisting mental health issues. The EU is unlikely to ban these drugs, but access may become more restricted due to ongoing debates.

      community Androgenetic alopecia is a skin disease: DHT-mediated skin disorders

      in Research/Science  64 upvotes 1 year ago
      Dihydrotestosterone (DHT) impacts various skin conditions, including Androgenetic alopecia and seborrheic dermatitis, by causing overactivity in sebaceous glands. Topical medications Tacrolimus and Clobetasol can reduce these inflammatory conditions, and treatments like RU58841, Minoxidil, and Finasteride may also be beneficial.

      community The mechanism of androgenic alopecia

      in Research/Science  32 upvotes 1 week ago
      DHT may inhibit hair growth by affecting mitochondrial function, leading to hair follicle miniaturization. Treatments like minoxidil and PP405 may promote hair growth by altering metabolic pathways, potentially counteracting DHT's effects.

      community I am a dermatologist with a clinical interest in alopecia. AMA

      in Will treatment work for me? 3 years ago
      In this conversation, 4990 discussed various treatments for hair loss, including oral minoxidil, PRP, transplan, Jak inhibitors, Dutasteride, Finasteride, Olumiant, Ketoconazole, RU58841, microneedling, baricitinib, and CCCA. They recommended scalp biopsies in unclear cases of DUPA, twice weekly to twice daily shampooing for topical minoxidil users, and two sessions spaced one month apart with follow up at month three to determine the effectiveness of PRP treatment.

      community Pyrilutamide ,the molecule’s true nature

      in Research  302 upvotes 1 year ago
      Pyrilutamide is a selective AR antagonist with a high binding affinity, making it effective in competing with DHT for androgen receptors. The 1% concentration is more effective than the 0.5%, but the latter may suffice for mild hair loss; the drug is considered a good option for those avoiding 5AR blockers due to side effects.

      community Why is human evolution like this 😂

      in Chat 3 years ago
      Why androgenic alopecia affects the scalp rather than other body parts, potential explanations for this phenomenon, treatments available to combat hair loss, and the implications of male attractiveness in modern society.

    Related Research

    1 / 1 results